Cytek Biosciences (NASDAQ:CTKB – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it compare to its peers? We will compare Cytek Biosciences to related businesses based on the strength of its dividends, analyst recommendations, profitability, earnings, institutional ownership, risk and valuation. Institutional & Insider Ownership 36.0% of […]